Ramcon to become Scandinavian distributor for ID Tag RVP (respiratory viral panel):
This article was originally published in Clinica
Executive Summary
Danish diagnostics product distributor Ramcon is to become exclusive distributor of the ID-Tag respiratory viral panel (RVP), developed by Canada's Tm Bioscience, in Denmark, Sweden, Finland and Norway. The ID-Tag RVP detects 20 respiratory viruses and subtypes, including avian flu and SARS, and runs on Luminex analysers, which Birkerod-based Ramcon also distribute across Scandinavia, said Tm Bioscience. The Toronto, Ontario firm has also secured distribution agreements for the test in the Netherlands and Turkey and said it plans to continue increasing its commercial distribution footprint across Europe in anticipation of regulatory approval - including FDA 510(k) clearance, Canadian approval and European CE-marking - of the product.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.